Wired Differently

AI-driven diagnostic tools for faster and more accurate assessment of Fetal Alcohol Spectrum Disorder (FASD), and educational programs for affected individuals, families, caregivers, educators and health providers.
We are determined to help solve the critical issues surrounding Fetal Alcohol Spectrum Disorder (FASD), a condition resulting from prenatal exposure to alcohol, causing irreversible damage to the central nervous system and presenting a range of physical and cognitive deficits. FASD's prevalence, estimated at 1-5% worldwide, often goes undiagnosed or misdiagnosed, contributing to a substantial economic burden and lengthy assessment waiting times, exacerbating the challenges for affected individuals and their families. Recognising the need for timely interventions, we aim to improve the approach to FASD through innovative AI-driven solutions, expediting assessments, reducing economic strain, and enhancing awareness among healthcare professionals and educators. Our goal is to make a profound impact on global health and social support systems by addressing the diagnostic gaps and economic implications associated with FASD.
A platform dedicated to addressing Fetal Alcohol Spectrum Disorder (FASD), our mission is to equip affected individuals, families, caregivers, educators, and health providers with essential knowledge and tools for improved support and care. The key offerings of our platform include specialised certification programs for healthcare professionals, educators, and caregivers, fostering a more informed and supportive community. We will introduce a Diagnostic Tool with AI Integration, leveraging artificial intelligence for faster and more accurate FASD assessments. This tool triangulates facial features, body abnormalities, questionnaire data, and image processing to reduce waiting times, enabling timely interventions. Additionally, our Prenatal Care Tool is designed to empower expectant individuals, healthcare providers, and educators with resources for prevention and early detection, aiming to reduce the prevalence of FASD.